0001181431-11-049333.txt : 20110914
0001181431-11-049333.hdr.sgml : 20110914
20110914184952
ACCESSION NUMBER: 0001181431-11-049333
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110912
FILED AS OF DATE: 20110914
DATE AS OF CHANGE: 20110914
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ZUERBLIS KENNETH J
CENTRAL INDEX KEY: 0001007923
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15313
FILM NUMBER: 111091426
MAIL ADDRESS:
STREET 1: 20 KINGSBRIDGE RD
CITY: PISCATAWAY
STATE: NJ
ZIP: 08854
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000722104
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 133033811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
BUSINESS PHONE: 7324189300
MAIL ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
FORMER COMPANY:
FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP
DATE OF NAME CHANGE: 19920703
3
1
rrd321895.xml
FORM 3
X0204
3
2011-09-12
0
0000722104
SAVIENT PHARMACEUTICALS INC
SVNT
0001007923
ZUERBLIS KENNETH J
ONE TOWER CENTER BLVD.
14TH FLOOR
EAST BRUNSWICK
NJ
08816
0
1
0
0
EVP, Chief Financial Officer
Option to Purchase Common Stock, $.01 par value
3.81
2011-12-12
2021-09-12
Common Stock, $.01 par value per share
300000
D
These options vest as to 25,000 shares of the grant at the end of each three-month period following September 12, 2011.
/s/ Irina Ishak as Attorney-In-Fact for Kenneth J. Zuerblis
2011-09-14